Month: October 2021
-
FDA Halts Off-the-Shelf T-Cell Cancer Trials
The Food and Drug Administration stopped a company’s clinical trials of off-the-shelf engineered T-cells after a patient showed an abnormal chromosomal reaction.
-
Precision Neuroscience Company Starts-Up, Raises $500M
A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science.
-
Partnership Seeks Lower-Cost Protein Drugs
A biotechnology enterprise and company aiming to make drugs at lower prices are collaborating on new lower-cost synthetic protein drugs.
-
Seed Stage Investors Raise $450M for New Fund
A venture capital company specializing in financing start-up enterprises at their earliest stages says it raised $450 million for its third venture fund.
-
Synthetic Antibody Company Goes Public in $230M Merger
A developer of synthetic antibodies for inflammatory and skin disorders is becoming a public company through a special purpose acquisition-merger.
-
Lab Checklist: What Makes a Great Laboratory?
Today, we will be discussing different aspects that every lab needs. From safety equipment to accuracy, we will cover all bases.
-
Infographic – Climate Disasters Rising for Next Gens
New research shows children born last year can expect to experience three times the number of adverse climate events in their lifetimes than earlier generations.
-
Elephant Genetic Codes to be Sequenced, Preserved
A biotechnology company using gene editing to preserve animal species is sequencing the genomes of three elephant varieties to help prevent their extinction.